BTC $82,440.63 -0.22%
ETH $2,493.26 -2.58%
BNB $741.90 -3.34%
XRP $1.40 -1.06%
SOL $110.55 -4.17%
TRX $0.3318 -1.10%
DOGE $0.0850 -3.86%
ADA $0.2356 -6.75%
BCH $279.07 -5.99%
LINK $12.84 -2.28%
HYPE $85.41 -2.39%
AAVE $166.00 -4.04%
SUI $1.05 -6.37%
XLM $0.1946 -2.03%
ZEC $1,216.67 -3.67%
AAPL $340.65 +1.31%
AMZN $255.98 -1.62%
GOOGL $349.87 -0.05%
MSFT $523.85 -1.07%
META $721.87 -0.05%
NVDA $232.75 -1.86%
TSLA $377.95 +0.27%
SNDK $1,635.93 -3.37%
INTC $108.15 -4.33%
SPCX $165.78 -1.26%
MU $1,051.52 -2.97%
AMD $628.63 -2.47%
BTC $82,440.63 -0.22%
ETH $2,493.26 -2.58%
BNB $741.90 -3.34%
XRP $1.40 -1.06%
SOL $110.55 -4.17%
TRX $0.3318 -1.10%
DOGE $0.0850 -3.86%
ADA $0.2356 -6.75%
BCH $279.07 -5.99%
LINK $12.84 -2.28%
HYPE $85.41 -2.39%
AAVE $166.00 -4.04%
SUI $1.05 -6.37%
XLM $0.1946 -2.03%
ZEC $1,216.67 -3.67%
AAPL $340.65 +1.31%
AMZN $255.98 -1.62%
GOOGL $349.87 -0.05%
MSFT $523.85 -1.07%
META $721.87 -0.05%
NVDA $232.75 -1.86%
TSLA $377.95 +0.27%
SNDK $1,635.93 -3.37%
INTC $108.15 -4.33%
SPCX $165.78 -1.26%
MU $1,051.52 -2.97%
AMD $628.63 -2.47%

上市公司 Galmed 拟将 50% 现金储备配置于加密货币

2025-08-25 20:00:41

ChainCatcher 消息,据 PR Newswire 报道,美股上市生物制药公司 Galmed Pharmaceuticals Ltd. 宣布实施数字资产管理战略,公司计划将 1000 万美元(约占当前现金储备的 50%)用于数字资产投资。

公司已成立加密货币委员会,负责评估和监督加密货币相关投资活动。该策略将包括数字资产投资组合再平衡、参与流动性提供、质押收益和风险对冲策略等。

为执行该计划,Galmed 已与加密货币资产管理服务商 Tectona(TASE:TECT)签署意向书,由后者提供咨询和运营服务。

app_icon
ChainCatcher 与创新者共建Web3世界